- Home
- TELA vs THTX Comparison
TELA vs THTX Comparison
Compare TELA & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TELA
- THTX
- Stock Information
- Founded
- TELA 2012
- THTX 1993
- Country
- TELA United States
- THTX Canada
- Employees
- TELA N/A
- THTX N/A
- Industry
- TELA Medical/Dental Instruments
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- TELA Health Care
- THTX Health Care
- Exchange
- TELA Nasdaq
- THTX Nasdaq
- Market Cap
- TELA 61.8M
- THTX 54.3M
- IPO Year
- TELA 2019
- THTX N/A
- Fundamental
- Price
- TELA $2.93
- THTX $1.79
- Analyst Decision
- TELA Strong Buy
- THTX Hold
- Analyst Count
- TELA 4
- THTX 1
- Target Price
- TELA $9.25
- THTX N/A
- AVG Volume (30 Days)
- TELA 132.9K
- THTX 85.1K
- Earning Date
- TELA 11-07-2024
- THTX 10-10-2024
- Dividend Yield
- TELA N/A
- THTX N/A
- EPS Growth
- TELA N/A
- THTX N/A
- EPS
- TELA N/A
- THTX N/A
- Revenue
- TELA $68,649,000.00
- THTX $84,316,000.00
- Revenue This Year
- TELA $30.39
- THTX $5.60
- Revenue Next Year
- TELA $25.51
- THTX $4.62
- P/E Ratio
- TELA N/A
- THTX N/A
- Revenue Growth
- TELA 29.34
- THTX 5.75
- 52 Week Low
- TELA $2.30
- THTX $1.08
- 52 Week High
- TELA $7.84
- THTX $2.58
- Technical
- Relative Strength Index (RSI)
- TELA 47.50
- THTX 70.56
- Support Level
- TELA $2.69
- THTX $1.40
- Resistance Level
- TELA $3.09
- THTX $1.56
- Average True Range (ATR)
- TELA 0.18
- THTX 0.12
- MACD
- TELA -0.03
- THTX 0.03
- Stochastic Oscillator
- TELA 30.77
- THTX 96.65
About TELA TELA Bio Inc.
TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.